{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:41Z","timestamp":1792090001475,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11228-2","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:01:02Z","timestamp":1789905662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond tumor response: hope and decision regret during immunotherapy for hepatocellular carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Huei-Shiuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Lii","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-1153","authenticated-orcid":false,"given":"Tsai-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"11228_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"11228_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"A-L Cheng","year":"2022","unstructured":"Cheng A-L, Qin S, Ikeda M et al (2022) Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol 76:862\u2013873. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.030","journal-title":"J Hepatol"},{"key":"11228_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"11228_CR4","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M et al (2022) Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid 1:EVIDoa2100070. https:\/\/doi.org\/10.1056\/EVIDoa2100070","journal-title":"NEJM Evid"},{"key":"11228_CR5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.23.02745","volume":"42","author":"JD Gordan","year":"2024","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK et al (2024) Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update. J Clin Oncol 42:1830\u20131850. https:\/\/doi.org\/10.1200\/JCO.23.02745","journal-title":"J Clin Oncol"},{"key":"11228_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318:197\u2013198. https:\/\/doi.org\/10.1001\/jama.2017.7156","journal-title":"JAMA"},{"key":"11228_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S1470-2045(21)00151-0","volume":"22","author":"PR Galle","year":"2021","unstructured":"Galle PR, Finn RS, Qin S et al (2021) Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial. Lancet Oncol 22:991\u20131001. https:\/\/doi.org\/10.1016\/S1470-2045(21)00151-0","journal-title":"Lancet Oncol"},{"key":"11228_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/0272989X16636113","volume":"36","author":"MM Becerra Perez","year":"2016","unstructured":"Becerra Perez MM, Menear M, Brehaut JC, Legare F (2016) Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Making 36:777\u2013790. https:\/\/doi.org\/10.1177\/0272989X16636113","journal-title":"Med Decis Making"},{"key":"11228_CR9","first-page":"285","volume-title":"Handbook of social and clinical psychology: the health perspective","author":"CR Snyder","year":"1991","unstructured":"Snyder CR, Irving LM, Anderson JR (1991) Hope and health. Handbook of social and clinical psychology: the health perspective. Pergamon Press, pp 285\u2013305"},{"key":"11228_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1365-2648.1992.tb01843.x","volume":"17","author":"K Herth","year":"1992","unstructured":"Herth K (1992) Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs 17:1251\u20131259. https:\/\/doi.org\/10.1111\/j.1365-2648.1992.tb01843.x","journal-title":"J Adv Nurs"},{"key":"11228_CR11","volume-title":"Designing and conducting mixed methods research","author":"JW Creswell","year":"2018","unstructured":"Creswell JW, Plano Clark VL (2018) Designing and conducting mixed methods research, 3rd ed. Sage Publications","edition":"3rd ed"},{"key":"11228_CR12","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1200\/JCO.20.02672","volume":"38","author":"JD Gordan","year":"2020","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK et al (2020) Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline. J Clin Oncol 38:4317\u20134345. https:\/\/doi.org\/10.1200\/JCO.20.02672","journal-title":"J Clin Oncol"},{"key":"11228_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O\u2019Connor AM, Wood TJ et al (2003) Validation of a decision regret scale. Med Decis Making 23:281\u2013292. https:\/\/doi.org\/10.1177\/0272989X03256005","journal-title":"Med Decis Making"},{"key":"11228_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/j.1365-2648.2011.05887.x","volume":"68","author":"KS Chan","year":"2012","unstructured":"Chan KS, Li HCW, Chan SW-C, Lopez V (2012) Herth hope index: psychometric testing of the Chinese version. J Adv Nurs 68:2079\u20132085. https:\/\/doi.org\/10.1111\/j.1365-2648.2011.05887.x","journal-title":"J Adv Nurs"},{"key":"11228_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpainsymman.2005.12.019","volume":"32","author":"C-C Lin","year":"2006","unstructured":"Lin C-C, Chang A-P, Chen M-L et al (2006) Validation of the Taiwanese version of the brief fatigue inventory. J Pain Symptom Manage 32:52\u201359. https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.12.019","journal-title":"J Pain Symptom Manage"},{"key":"11228_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209344","volume":"13","author":"H-W Lin","year":"2018","unstructured":"Lin H-W, Li C-I, Lin F-J et al (2018) Valuation of the EQ-5D-5L in Taiwan. PLoS ONE 13:e0209344. https:\/\/doi.org\/10.1371\/journal.pone.0209344","journal-title":"PLoS ONE"},{"key":"11228_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ et al (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6\u20139","journal-title":"J Palliat Care"},{"key":"11228_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang K-Y (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121\u2013130","journal-title":"Biometrics"},{"key":"11228_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D (2013) Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol 4:863. https:\/\/doi.org\/10.3389\/fpsyg.2013.00863","journal-title":"Front Psychol"},{"key":"11228_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qual Res Psychol"},{"key":"11228_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1370\/afm.1865","volume":"13","author":"TC Guetterman","year":"2015","unstructured":"Guetterman TC, Fetters MD, Creswell JW (2015) Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med 13:554\u2013561. https:\/\/doi.org\/10.1370\/afm.1865","journal-title":"Ann Fam Med"},{"key":"11228_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/20597991231188121","volume":"16","author":"A Younas","year":"2023","unstructured":"Younas A, Fabregues S, Creswell JW (2023) Generating metainferences in mixed methods research: a worked example in convergent mixed methods designs. Methodol Innov 16:276\u2013291. https:\/\/doi.org\/10.1177\/20597991231188121","journal-title":"Methodol Innov"},{"key":"11228_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2165\/00019053-200725050-00002","volume":"25","author":"AS Pickard","year":"2007","unstructured":"Pickard AS, Wilke CT, Lin H-W, Lloyd A (2007) Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics 25:365\u2013384. https:\/\/doi.org\/10.2165\/00019053-200725050-00002","journal-title":"Pharmacoeconomics"},{"key":"11228_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/1467-8721.00203","volume":"11","author":"T Connolly","year":"2002","unstructured":"Connolly T, Zeelenberg M (2002) Regret in decision making. Curr Dir Psychol Sci 11:212\u2013216. https:\/\/doi.org\/10.1111\/1467-8721.00203","journal-title":"Curr Dir Psychol Sci"},{"key":"11228_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1891\/1061-3749.20.1.21","volume":"20","author":"RLJ Hickman","year":"2012","unstructured":"Hickman RLJ, Pinto MD, Lee E, Daly BJ (2012) Exploratory and confirmatory factor analysis of the decision regret scale in recipients of internal cardioverter defibrillators. J Nurs Meas 20:21\u201334. https:\/\/doi.org\/10.1891\/1061-3749.20.1.21","journal-title":"J Nurs Meas"},{"key":"11228_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist 18:381\u2013390. https:\/\/doi.org\/10.1634\/theoncologist.2012-0279","journal-title":"Oncologist"},{"key":"11228_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","volume":"34","author":"SD Ramsey","year":"2016","unstructured":"Ramsey SD, Bansal A, Fedorenko CR et al (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34:980\u2013986. https:\/\/doi.org\/10.1200\/JCO.2015.64.6620","journal-title":"J Clin Oncol"},{"key":"11228_CR28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s11136-025-03923-0","volume":"34","author":"HT Hasse","year":"2025","unstructured":"Hasse HT, Kjaer T, Kristensen SR (2025) Trajectory of quality of life among patients with cancer at the end of life: a longitudinal survey study. Qual Life Res 34:1695\u20131707. https:\/\/doi.org\/10.1007\/s11136-025-03923-0","journal-title":"Qual Life Res"},{"key":"11228_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05638-0","volume":"150","author":"A Ruhle","year":"2024","unstructured":"Ruhle A, Wieland L, Hinz A et al (2024) Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany. J Cancer Res Clin Oncol 150:167. https:\/\/doi.org\/10.1007\/s00432-024-05638-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"11228_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pec.2015.11.019","volume":"99","author":"J Nicolai","year":"2016","unstructured":"Nicolai J, Buchholz A, Seefried N et al (2016) When do cancer patients regret their treatment decision? A path analysis of the influence of clinicians\u2019 communication styles and the match of decision-making styles on decision regret. Patient Educ Couns 99:739\u2013746. https:\/\/doi.org\/10.1016\/j.pec.2015.11.019","journal-title":"Patient Educ Couns"},{"key":"11228_CR31","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1111\/jocn.16140","volume":"31","author":"C Li","year":"2022","unstructured":"Li C, Lu X, Xiao J, Chan CWH (2022) \u201cWe can bear it!\u201d Unpacking barriers to hepatocellular carcinoma screening among patients with hepatitis B: a qualitative study. J Clin Nurs 31:3130\u20133143. https:\/\/doi.org\/10.1111\/jocn.16140","journal-title":"J Clin Nurs"},{"key":"11228_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100474","volume":"7","author":"I Kiss","year":"2022","unstructured":"Kiss I, Kuhn M, Hrusak K, Buchler T (2022) Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis. ESMO Open 7:100474. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100474","journal-title":"ESMO Open"},{"key":"11228_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6316","volume":"33","author":"LE McLouth","year":"2024","unstructured":"McLouth LE, Shelton BJ, Bursac V et al (2024) \u201cPathways\u201d: a hope-enhancing intervention for patients undergoing treatment for advanced lung cancer. Psychooncology 33:e6316. https:\/\/doi.org\/10.1002\/pon.6316","journal-title":"Psychooncology"},{"key":"11228_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/HEP.0000000000001269","volume":"82","author":"TH Taddei","year":"2025","unstructured":"Taddei TH, Brown DB, Yarchoan M et al (2025) Critical update: AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 82:272\u2013274. https:\/\/doi.org\/10.1097\/HEP.0000000000001269","journal-title":"Hepatology"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11228-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11228-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11228-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:42Z","timestamp":1792086462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11228-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11228"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11228-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of National Taiwan University Hospital (NTUH-REC No.: 202211075RIND).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"992"}}